Longport, Inc. Signs Distribution Agreement with Maximum Medical Inc.; Distributor Initially Purchases 6 Demonstration Scanners

Longport, Inc. (OTC BB: LPTI), a medical technology
specialist in high resolution ultrasound imaging, today announced that
it has signed a distribution agreement with Maximum Medical Inc, of
Savanna, GA. Maximum Medical is an established medical marketing,
sales, and service company specializing in wound care that has a sales
force of more than 35 sales representatives operating from their
offices in Orlando, FL, Savanna, GA, Dallas, TX, and Houston, TX. (See
www.maxmed-usa.com)
   Initially, Maximum Medical has placed an order for six
demonstration EPISCAN systems and are expected to require an
additional two demonstration units in the third quarter of 2005 as
they roll out their EPISCAN sales and marketing program. Maximum
Medical will be launching this program at the Wound Ostomy and
Continence Nurses Society (WOCN) 37th Annual Conference in Las Vegas,
between June 12th and 16th. This congress is expected to attract some
4,000 delegates. Longport staff will be supporting Maximum Medical at
the WOCN Conference.
   John Calabrese, Director of Sales and Marketing with Longport,
said, "We believe this will be a very profitable relationship for both
companies, and one that gives Longport greater market penetration.
Maximum Medical is an established supplier of medical devices to
clinics, hospitals, and nursing homes, and we will benefit from their
existing relationships as well as the strength of the sales team in
developing new business."
   Greg Stewart, National Director of Sales and Operations with
Maximum Medical, said, "We believe the addition of Longport's EPISCAN
I-200 to our current product line truly makes us a total wound care
and prevention company that promotes better patient care to our
customer base. Welcome to the future of wound care!"

   About Longport, Inc. 

   Longport, Inc. of Glen Mills, Pennsylvania, is a medical
technology company that specializes in high resolution ultrasound
imaging. After several years and a multi-million dollar investment in
the technology, Longport has secured patents, copyrights, and FDA
permission to market. The Company's technology has been used to
engineer a unique high resolution ultrasound imaging system. For
further information please contact Longport, Inc. at 1-800-289-6863 or
visit our website at www.longportinc.com.

   Forward-looking Information and the Private Securities Litigation
Reform Act of 1995 

   Certain statements in this press release, including statements
concerning product development milestones and anticipated events, are
"forward-looking statements" within the Private Litigation Reform Act
of 1995. Forward Looking Statements are based on the opinions and
estimates of management at the time the statements are made and are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those anticipated in the
forward-looking statements. The words "believe," "expect," "intend,"
"anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect Longport's actual results include, among others,
uncertainties as to the Company's ability to manage potential
problems, delays or anticipated expenses, including problems, delays
or expenses involving manufacturing. Readers are cautioned not to
place undue reliance upon these forward-looking statements that speak
only to the date of this release. Reference is made to Longport's 2004
annual report on Form 10-K filed with the Securities and Exchange
Commission for a more definitive description of such factors.
Longport, Inc. undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.